dc.creatorFierro Silva, Hernán Alejandro
dc.creatorMartínez, Juan Carlos
dc.date.accessioned2019-03-11T12:55:00Z
dc.date.available2019-03-11T12:55:00Z
dc.date.created2019-03-11T12:55:00Z
dc.date.issued2007
dc.identifierRevista Medica de Chile, Volumen 135, Issue 9, 2018, Pages 1195-1201
dc.identifier00349887
dc.identifier07176163
dc.identifierhttps://repositorio.uchile.cl/handle/2250/164433
dc.description.abstractThe use of antidepressant in depressive illness results in a reduction of suicidal attempts and deaths due to suicide, conditions that are generally present in this disorder. Recently, the Federal Drug Administration (FDA) prohibited the use of antidepressants during childhood and adolescence. This decision was based on a supposed increase in suicidal thinking in these age groups. However, the evidence came from flawed clinical studies, some of them not even published, in which no significant differences were observed when compared to placebo. It is not possible to ascribe a direct responsibility to antidepressants, because depression, by definition, has suicidal ideation. On the contrary, the reduction of suicidal rates supports the effectiveness of these medications.
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceRevista Medica de Chile
dc.subjectAdolescent
dc.subjectAntidepressive agents
dc.subjectChild, preschool
dc.subjectDepression
dc.subjectSuicide
dc.titleDo antidepressants really increase suicide rates in childhood and adolescence? Es efectivo que los antidepresivos aumentan el riesgo de suicidio?
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución